CEREVEL THERAPEUTICS HLDNG I's ticker is CERE and the CUSIP is 15678U128. A total of 123 filers reported holding CEREVEL THERAPEUTICS HLDNG I in Q3 2023. The put-call ratio across all filers is 1.64 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $79,068 | -26.8% | 3,622 | +6.6% | 0.00% | -20.0% |
| Q2 2023 | $108,022 | +34.4% | 3,398 | +3.1% | 0.01% | +25.0% |
| Q1 2023 | $80,365 | -29.0% | 3,295 | -8.1% | 0.00% | -20.0% |
| Q4 2022 | $113,134 | +19.6% | 3,587 | +7.2% | 0.01% | 0.0% |
| Q3 2022 | $94,586 | +6.9% | 3,347 | 0.0% | 0.01% | +25.0% |
| Q2 2022 | $88,495 | -9.8% | 3,347 | +19.4% | 0.00% | 0.0% |
| Q1 2022 | $98,133 | -75.0% | 2,803 | -76.8% | 0.00% | -20.0% |
| Q4 2021 | $391,893 | +13.2% | 12,088 | +3.0% | 0.01% | 0.0% |
| Q3 2021 | $346,124 | +11.2% | 11,733 | -3.5% | 0.01% | +25.0% |
| Q2 2021 | $311,360 | – | 12,153 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BAIN CAPITAL INVESTORS LLC | 60,632,356 | $1,965,701,000 | 23.51% |
| Affinity Asset Advisors, LLC | 225,000 | $7,295,000 | 2.65% |
| Perceptive Advisors | 10,173,454 | $329,822,000 | 2.54% |
| Artal Group S.A. | 1,500,000 | $48,630,000 | 1.32% |
| Rock Springs Capital Management LP | 1,648,435 | $53,442,000 | 1.24% |
| RTW INVESTMENTS, LP | 666,666 | $21,613,000 | 0.32% |
| BOULDER HILL CAPITAL MANAGEMENT LP | 8,900 | $289,000 | 0.28% |
| EAM Investors, LLC | 39,907 | $1,294,000 | 0.21% |
| FEDERATED HERMES, INC. | 3,113,333 | $100,934,000 | 0.19% |
| Alkeon Capital Management | 1,909,035 | $61,891,000 | 0.12% |